Control Group Nā=ā138 | |||||||||
Ā | LoS ā¤ā5Ā days | LoS 6ā9 days | LoS ā„ā10Ā days | ||||||
āASA grade 1 | nā=ā37 | 26 (70Ā %) | 9 (24Ā %) | 2 (5Ā %) | |||||
āASA grade 2 | nā=ā83 | 45 (54Ā %) | 27 (35Ā %) | 11 (13Ā %) | |||||
āASA grade 3 | nā=ā18 | 4 (22Ā %) | 6 (33Ā %) | 8 (44Ā %) | |||||
Intervention group Nā=ā107 a | |||||||||
āASA grade 1 | nā=ā21 | 14 (67Ā %) | 7 (33Ā %) | 0 | |||||
āASA grade 2 | nā=ā61 | 35 (57Ā %) | 22 (36Ā %) | 4 (7Ā %) | |||||
āASA grade 3 | nā=ā25 | 18 (72Ā %) | 2 (28Ā %) | 0 | |||||
Overall LoS for patients with ASA grade 1 | |||||||||
Ā | Mean LoS | SD | Range | Diff | Age \( \overset{\hbox{--} }{\mathrm{x}} \) (Median) | 95Ā % CI | P-value | ||
āControl Group | nā=ā37 | 5.65 | 2.97 | 18Ā days | 0.84 | 57 (58) | ā0.58 | 2.26 | 0.28 |
āgPCC Group | nā=ā21 | 4.81 | 1.72 | 9Ā days | 67 (64) | ||||
Overall LoS for patients with ASA grade 2 | |||||||||
Ā | Mean LoS | SD | Range | Diff | Age \( \overset{\hbox{--} }{\mathrm{x}} \) (Median) | 95Ā % CI | P-value | ||
āControl Group | nā=ā83 | 6.65 | 3.81 | 25Ā days | 0.81 | 67 (67) | ā0.3 | 1.93 | 0.15 |
āgPCC Group | nā=ā61 | 5.84 | 2.52 | 13Ā days | 76 (78) | ||||
Overall LoS for patients with ASA grade 3b | |||||||||
Ā | Mean LoS | SD | Range | Diff | Age \( \overset{\hbox{--} }{\mathrm{x}} \) (Median) | 95Ā % CI | P-value | ||
āControl Group | nā=ā18 | 11.50 | 9.36 | 40Ā days | 6.78 | 73 (73) | 2.94 | 10.62 | 0.001 |
āgPCC Group | nā=ā25 | 4.72 | 1.57 | 7Ā days | 69 (71) |